These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 32350063)

  • 1. Regional Proteomic Quantification of Clinically Relevant Non-Cytochrome P450 Enzymes along the Human Small Intestine.
    Zhang H; Wolford C; Basit A; Li AP; Fan PW; Murray BP; Takahashi RH; Khojasteh SC; Smith BJ; Thummel KE; Prasad B
    Drug Metab Dispos; 2020 Jul; 48(7):528-536. PubMed ID: 32350063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human.
    Basit A; Neradugomma NK; Wolford C; Fan PW; Murray B; Takahashi RH; Khojasteh SC; Smith BJ; Heyward S; Totah RA; Kelly EJ; Prasad B
    Mol Pharm; 2020 Nov; 17(11):4114-4124. PubMed ID: 32955894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis.
    Fritz A; Busch D; Lapczuk J; Ostrowski M; Drozdzik M; Oswald S
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):245-255. PubMed ID: 30253071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based targeted proteomics method for the quantification of clinically relevant drug metabolizing enzymes in human specimens.
    Wenzel C; Drozdzik M; Oswald S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1180():122891. PubMed ID: 34390906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
    Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione S-transferase, cytochrome P450, and uridine 5'-diphosphate-glucuronosyltransferase in human small intestine and liver.
    Peters WH; Nagengast FM; van Tongeren JH
    Gastroenterology; 1989 Mar; 96(3):783-9. PubMed ID: 2492479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human.
    Akazawa T; Uchida Y; Miyauchi E; Tachikawa M; Ohtsuki S; Terasaki T
    Mol Pharm; 2018 Jan; 15(1):127-140. PubMed ID: 29140712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative ADME proteomics - CYP and UGT enzymes in the Beagle dog liver and intestine.
    Heikkinen AT; Friedlein A; Matondo M; Hatley OJ; Petsalo A; Juvonen R; Galetin A; Rostami-Hodjegan A; Aebersold R; Lamerz J; Dunkley T; Cutler P; Parrott N
    Pharm Res; 2015 Jan; 32(1):74-90. PubMed ID: 25033762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine.
    Couto N; Al-Majdoub ZM; Gibson S; Davies PJ; Achour B; Harwood MD; Carlson G; Barber J; Rostami-Hodjegan A; Warhurst G
    Drug Metab Dispos; 2020 Apr; 48(4):245-254. PubMed ID: 31959703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants.
    Boberg M; Vrana M; Mehrotra A; Pearce RE; Gaedigk A; Bhatt DK; Leeder JS; Prasad B
    Drug Metab Dispos; 2017 Feb; 45(2):216-223. PubMed ID: 27895113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-individual and inter-regional variations in enteric drug metabolizing enzyme activities: Results with cryopreserved human intestinal mucosal epithelia (CHIM) from the small intestines of 14 donors.
    Li AP; Ho MD; Alam N; Mitchell W; Wong S; Yan Z; Kenny JR; E C A Hop C
    Pharmacol Res Perspect; 2020 Oct; 8(5):e00645. PubMed ID: 32851819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Hepatic UDP-Glucuronosyltransferase Enzyme Abundance-Activity Correlations and Population Variability Using a Proteomics Approach and Comparison with Cytochrome P450 Enzymes.
    Takahashi RH; Forrest WF; Smith AD; Badee J; Qiu N; Schmidt S; Collier AC; Parrott N; Fowler S
    Drug Metab Dispos; 2021 Sep; 49(9):760-769. PubMed ID: 34187837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Accurate Composition and Total Abundance of Homologous Proteins by Conserved-Plus-Surrogate Peptide Approach: Quantification of UDP Glucuronosyltransferases in Human Tissues.
    Ahire D; Patel M; Deshmukh SV; Prasad B
    Drug Metab Dispos; 2023 Mar; 51(3):285-292. PubMed ID: 36446609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics.
    Achour B; Russell MR; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Apr; 42(4):500-10. PubMed ID: 24408517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.
    Argikar UA; Potter PM; Hutzler JM; Marathe PH
    AAPS J; 2016 Nov; 18(6):1391-1405. PubMed ID: 27495117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 and phase 2 metabolic activities along the small intestine in adult male sheep.
    Maté L; Virkel G; Lifschitz A; Sallovitz J; Ballent M; Lanusse C
    J Vet Pharmacol Ther; 2010 Dec; 33(6):537-45. PubMed ID: 21062305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of CYP450 Expression Levels in the Human Small Intestine by Mass Spectrometry-Based Targeted Proteomics.
    Grangeon A; Clermont V; Barama A; Gaudette F; Turgeon J; Michaud V
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine.
    Clermont V; Grangeon A; Barama A; Turgeon J; Lallier M; Malaise J; Michaud V
    Br J Clin Pharmacol; 2019 Jun; 85(6):1367-1377. PubMed ID: 30817016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
    Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
    Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.